Income Statement Balance Sheet Cash Flow Statement
Annual Financials for TherapeuticsMD Inc.
Fiscal year is January-December. All values USD millions. 2010 2011 2012 2013 5-year trend
Sales/Revenue - 48,217 2.09M 3.82M 8.78M
Cost of Goods Sold (COGS) incl. D&A - 133,315 1M 1.4M 2.02M
COGS excluding D&A - 71,932 947,112 1.35M 1.96M
Depreciation & Amortization Expense - 61,383 54,845 56,260 58,145
Depreciation - 61,383 54,845 27,484 45,145
Amortization of Intangibles - 0 0 28,776 13,000
Gross Income - (85,098) 1.09M 2.41M 6.76M
2010 2011 2012 2013 5-year trend
SG&A Expense - 382,861 6.51M 18.56M 32.82M
Research & Development - - 107,241 4.49M 13.55M
Other SG&A - 382,861 6.41M 14.07M 19.26M
Other Operating Expense - 0 0 0 0
Unusual Expense - 0 7.39M 17.02M (249,981)
EBIT after Unusual Expense - 0 (7.39M) (17.02M) 249,981
Non Operating Income/Expense - 22,138 (31,767) 3,001 34,544
Non-Operating Interest Income - - - - 27,234
Equity in Affiliates (Pretax) - 0 0 0 0
Interest Expense - 64,086 64,380 1.95M 2.67M
Gross Interest Expense - 64,086 64,380 1.95M 2.67M
Interest Capitalized - 0 0 0 0
Pretax Income - (509,907) (12.91M) (35.12M) (28.42M)
Income Tax - 0 0 0 0
Income Tax - Current Domestic - 0 0 0 -
Income Tax - Current Foreign - 0 0 0 -
Income Tax - Deferred Domestic - 0 0 0 -
Income Tax - Deferred Foreign - 0 0 0 -
Income Tax Credits - 0 0 0 -
Equity in Affiliates - 0 0 0 0
Other After Tax Income (Expense) - 0 0 0 0
Consolidated Net Income - (509,907) (12.91M) (35.12M) (28.42M)
Minority Interest Expense - 0 0 0 0
Net Income - (509,907) (12.91M) (35.12M) (28.42M)
Extraordinaries & Discontinued Operations - (185,468) 0 0 0
Extra Items & Gain/Loss Sale Of Assets - 259,693 0 0 0
Cumulative Effect - Accounting Chg - 0 0 0 0
Discontinued Operations - (445,161) 0 0 0
Net Income After Extraordinaries - (695,375) (12.91M) (35.12M) (28.42M)
Preferred Dividends - 0 0 0 0
Net Income Available to Common - (509,907) (12.91M) (35.12M) (28.42M)
EPS (Basic) - (6.00) (0.21) (0.38) (0.22)
Basic Shares Outstanding - 164,205 62.52M 91.63M 127.57M
EPS (Diluted) - (6.00) (0.21) (0.38) (0.22)
Diluted Shares Outstanding - 164,205 62.52M 91.63M 127.57M
EBITDA - (406,576) (5.37M) (16.09M) (26M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.